Skip navigation
BelSU DSpace logo

Please use this identifier to cite or link to this item: http://dspace.bsu.edu.ru/handle/123456789/46602
Title: Study of aversive and p38 mapk-inhibitory properties of kappa-agonist with analgesic activity-compound RU-1205
Authors: Spasov, A. A.
Zvartau, E. E.
Grechko, O. I.
Eliseeva, N. V.
Semenova, Yu. V.
Keywords: medicine
pharmacology
dysphoria
kappa-opioid receptor
p38 MAPK-kinase
butorphanol
morphine
Issue Date: 2020
Citation: Study of aversive and p38 mapk-inhibitory properties of kappa-agonist with analgesic activity-compound RU-1205 / A.A. Spasov [et al.] // Research Results in Pharmacology. - 2020. - Vol.6, №3.-P. 59-65. - Doi: 10.3897/rrpharmacology.6.54558.
Abstract: The clinical use of kappa-opioid agonists, despite their lack of significant drug potential, is limited by the development of severe sedation, dysphoria, depression, and anhedonia. To this date, there are kappa-opioid receptor agonists lacking these side effects due to the selective activation of intracellular signal transmission pathways without p38-MAPK-kinase activation
URI: http://dspace.bsu.edu.ru/handle/123456789/46602
Appears in Collections:Vol. 6, № 3

Files in This Item:
File Description SizeFormat 
Spasov_Study of aversive.pdf746.96 kBAdobe PDFView/Open
Show full item record


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.